1. Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer. Issue 1 (2nd January 2023) Authors: Yang, James Chih-Hsin; Zhou, Caicun; Jänne, Pasi A.; Ramalingam, Suresh S.; Kim, Tae Min; Riely, Gregory J; Spira, Alexander I; Piotrowska, Zofia; Mekhail, Tarek; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Bazhenova, Lyudmila; Jin, Shu; Kaur, Manmit; Diderichsen, Paul M.; Gupta, Neeraj; Bun... Journal: Expert review of anticancer therapy Issue: Volume 23:Issue 1(2023) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison. (May 2023) Authors: Ou, Sai-Hong I.; Lin, Huamao M.; Hong, Jin-Liern; Yin, Yu; Jin, Shu; Lin, Jianchang; Mehta, Minal; Zhang, Pingkuan; Nguyen, Danny; Neal, Joel W. Journal: Lung cancer Issue: Volume 179(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study. (March 2022) Authors: Popat, Sanjay; Ramalingam, Suresh; Kim, Tae Min; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Spira, Alexander; Piotrowska, Zofia; Bazhenova, Lyudmila; Vincent, Sylvie; Jin, Shu; Griffin, Celina; Diderichsen, Paul; Gupta, Neeraj; Bun... Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study. (April 2023) Authors: Popat, Sanjay; Ramalingam, Suresh; Zhou, Caicun; Kim, Tae; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Misch, Daniel; Kaur, Manmit; Bunn, Veronica; Lin, Huamao; Zhang, Pingkuan; Jänne, Pasi Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Parametric Presburger arithmetic: complexity of counting and quantifier elimination. Issue 2 (2nd September 2019) Authors: Bogart, Tristram; Goodrick, John; Nguyen, Danny; Woods, Kevin Journal: Mathematical logic quarterly Issue: Volume 65:Issue 2(2019) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Utility of Inflammatory Markers to Predict Adverse Outcome in Acute Pancreatitis: A Retrospective Study in a Tertiary Care Academic Center: 60. (October 2019) Authors: Mubder, Mohamad I.; Dhindsa, Banreet; Nguyen, Danny; Saghir, Syed; Cross, Chad; Makar, Ranjit; Ohning, Gordon Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Issue 5 (May 2023) Authors: Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew S; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon M; Lenz, Heinz-Josef; Ciombor, Kristen K; Elez, Elena; Bajor, David L; Cre... Journal: Lancet oncology Issue: Volume 24:Issue 5(2023) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗